Conflicts of interest None declared.
Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema
Article first published online: 23 OCT 2008
© 2008 The Authors. Journal Compilation © 2008 British Association of Dermatologists
British Journal of Dermatology
Volume 160, Issue 2, pages 353–358, February 2009
How to Cite
Diepgen, T.L., Andersen, K.E., Brandao, F.M., Bruze, M., Bruynzeel, D.P., Frosch, P., Gonçalo, M., Goossens, A., Le Coz, C.J., Rustemeyer, T., White, I.R., Agner, T. and on behalf of the European Environmental and Contact Dermatitis Research Group (2009), Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema. British Journal of Dermatology, 160: 353–358. doi: 10.1111/j.1365-2133.2008.08907.x
European Environmental and Contact Dermatitis Research Group: http://orgs.dermis.net/content/e05eecdrg/index_ger.html
- Issue published online: 16 JAN 2009
- Article first published online: 23 OCT 2008
- Accepted for publication 8 August 2008
- hand eczema;
Background Hand eczema is a long-lasting disease with a high prevalence in the background population. The disease has severe, negative effects on quality of life and sometimes on social status. Epidemiological studies have identified risk factors for onset and prognosis, but treatment of the disease is rarely evidence based, and a classification system for different subdiagnoses of hand eczema is not agreed upon. Randomized controlled trials investigating the treatment of hand eczema are called for. For this, as well as for clinical purposes, a generally accepted classification system for hand eczema is needed.
Objectives The present study attempts to characterize subdiagnoses of hand eczema with respect to basic demographics, medical history and morphology.
Methods Clinical data from 416 patients with hand eczema from 10 European patch test clinics were assessed.
Results A classification system for hand eczema is proposed.
Conclusions It is suggested that this classification be used in clinical work and in clinical trials.